Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 21, 2014; 20(27): 8796-8806
Published online Jul 21, 2014. doi: 10.3748/wjg.v20.i27.8796
Irritable bowel syndrome: A concise review of current treatment concepts
Geoffrey C Wall, Ginelle A Bryant, Michelle M Bottenberg, Erik D Maki, Andrew R Miesner
Geoffrey C Wall, Ginelle A Bryant, Michelle M Bottenberg, Erik D Maki, Andrew R Miesner, Department of Pharmacy Practice, Drake University College of Pharmacy, Des Moines, IA 50311, United States
Author contributions: All authors participated in literature review, retrieval, synthesis as well as writing this paper
Correspondence to: Geoffrey C Wall, Pharm.D., FCCP, BCPS, CGP, Department of Pharmacy Practice, Drake University College of Pharmacy, 2507 University Ave., Des Moines, IA 50311, United States. geoff.wall@drake.edu
Telephone: +1-515-2414297 Fax: +1-515-2415085
Received: September 27, 2013
Revised: March 4, 2014
Accepted: June 14, 2014
Published online: July 21, 2014
Core Tip

Core tip: Gastroenterology practitioners have more agents than ever before to treat the symptoms associated with irritable bowel syndrome. Unfortunately, despite advances in our understanding of the pathophysiology of this disorder, targeted treatments do not yet exist. This review summarizes the recent evidence-based treatment of this disorder, including, older and newer agents.